Immuneering Corp — Director's Dealing 2022

Mar 1, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Immuneering Corp (IMRX)
CIK: 0001790340
Period of Report: 2022-02-28

Reporting Person: Zeskind Benjamin J. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-02-28	Class A Common Stock	M	2000	$3.01	Acquired	2254352	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-02-28	Stock Option	$3.01	M	2000	Disposed	2029-12-15	Class A Common Stock (2000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	894927	Indirect

Footnotes

F1: Held by the Benjamin J. Zeskind 2020 Family Trust, where Lisa Schwartz, Dr. Zeskind's spouse, serves as sole trustee.

F2: The option has fully vested and is currently exercisable.